{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:39:25Z","timestamp":1788863965695,"version":"build-2803163510"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T00:00:00Z","timestamp":1228176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s12016-008-8112-z","type":"journal-article","created":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T13:30:37Z","timestamp":1228138237000},"page":"131-140","source":"Crossref","is-referenced-by-count":88,"title":["Renal Involvement in the Antiphospholipid Syndrome (APS)\u2014APS Nephropathy"],"prefix":"10.1007","volume":"36","author":[{"given":"Maria G.","family":"Tektonidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,2]]},"reference":[{"key":"8112_CR1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309\u20131311","journal-title":"Arthritis Rheum"},{"key":"8112_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"8112_CR3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0140-6736(93)93070-H","volume":"341","author":"GR Hughes","year":"1993","unstructured":"Hughes GR (1993) The antiphospholipid syndrome: ten years on. Lancet 341:342\u2013344","journal-title":"Lancet"},{"key":"8112_CR4","first-page":"1742","volume":"15","author":"RA Asherson","year":"1988","unstructured":"Asherson RA, Kant KS (1988) A \u201cprimary\u201d antiphospholipid syndrome. J Rheumatol 15:1742\u20131746","journal-title":"J Rheumatol"},{"key":"8112_CR5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019\u20131027","journal-title":"Arthritis Rheum"},{"key":"8112_CR6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","volume":"112","author":"PE Love","year":"1990","unstructured":"Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann Intern Med J 112:682\u2013689","journal-title":"Ann Intern Med J"},{"key":"8112_CR7","first-page":"47","volume":"2","author":"EN Harris","year":"1984","unstructured":"Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GR (1984) Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 2:47\u201351","journal-title":"Clin Exp Rheumatol"},{"key":"8112_CR8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.49.3.184","volume":"49","author":"PA Ostuni","year":"1990","unstructured":"Ostuni PA, Lazzarin P, Pengo V et al (1990) Renal artery thrombosis and hypertension in a 13\u00a0year old girl with antiphospholipid syndrome. Ann Rheum Dis 49:184\u2013187","journal-title":"Ann Rheum Dis"},{"key":"8112_CR9","first-page":"1413","volume":"18","author":"RA Asherson","year":"1991","unstructured":"Asherson RA, Noble GE, Hughes GRV (1991) Hypertension and renal stenosis in the primary antiphospholipid syndrome. J Rheumatol 18:1413\u20131415","journal-title":"J Rheumatol"},{"key":"8112_CR10","first-page":"1802","volume":"10","author":"PR Ames","year":"1992","unstructured":"Ames PR, Cianciaruso B, Belizzi V et al (1992) Bilateral renal artery occlusion in a patient with the primary antiphospholipid syndrome: thrombosis, vasculitis or both? J Rheumatol 10:1802\u20131806","journal-title":"J Rheumatol"},{"key":"8112_CR11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/ard.51.10.1180-b","volume":"51","author":"E Rossi","year":"1992","unstructured":"Rossi E, Sani C, Zini M, Casoli MC, Restori G (1992) Anticardiolipin antibodies and renovascular hypertension. Ann Rheum Dis 51:1180\u20131181","journal-title":"Ann Rheum Dis"},{"key":"8112_CR12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0272-6386(12)70264-0","volume":"20","author":"M Mandreoli","year":"1992","unstructured":"Mandreoli M, Zuccala A, Zucchelli P (1992) Fibromuscular dysplasia of the renal arteries associated with antiphospholipid autoantibodies: two cases reports. Am J Kidney Dis 20:500\u2013503","journal-title":"Am J Kidney Dis"},{"key":"8112_CR13","first-page":"1277","volume":"8","author":"M Mandreoli","year":"1993","unstructured":"Mandreoli M, Zucchelli P (1993) Renal vascular disease in patients with primary antiphospholipid autoantibodies. Nephrol Dial Transplant 8:1277\u20131280","journal-title":"Nephrol Dial Transplant"},{"key":"8112_CR14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0272-6386(96)90109-2","volume":"27","author":"JM Poux","year":"1996","unstructured":"Poux JM, Boudet R, Lacroix P et al (1996) Renal infarction and thrombosis of the infrarenal aorta in 35\u00a0year-old man with primary antiphospholipid syndrome. Am J Kidney Dis 27:721\u2013725","journal-title":"Am J Kidney Dis"},{"key":"8112_CR15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/qjmed\/93.2.127","volume":"93","author":"T Godfrey","year":"2000","unstructured":"Godfrey T, Khamashta MA, Hughes GRV (2000) Antiphospholipid syndrome and renal artery stenosis. QJM 93:127\u2013129","journal-title":"QJM"},{"key":"8112_CR16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard.62.10.999","volume":"62","author":"SR Sangle","year":"2003","unstructured":"Sangle SR, D\u2019 Cruz DP, Jan W et al (2003) Renal artery stenosis in the antiphospholipid syndrome (Hughes) syndrome and hypertension. Ann Rheum Dis 62:999\u20131002","journal-title":"Ann Rheum Dis"},{"key":"8112_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/096120330000900112","volume":"9","author":"GI Remondino","year":"2000","unstructured":"Remondino GI, Mysler E, Pissano MN et al (2000) A reversible bilateral renal artery stenosis in association with antiphopsholipid syndrome. Lupus 9:65\u201367","journal-title":"Lupus"},{"key":"8112_CR18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/rheumatology\/keh490","volume":"44","author":"SR Sangle","year":"2005","unstructured":"Sangle SR, D\u2019 Cruz DP, Abbs IC, Khamashta MA, Hughes GR (2005) Renal artery stenosis in hypertensive patients with antiphospholipid syndrome (Hughes syndrome): outcome following anticoagulation. Rheumatology (Oxford) 44:372\u2013377","journal-title":"Rheumatology (Oxford)"},{"key":"8112_CR19","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/ndt\/13.10.2645","volume":"13","author":"R Rysana","year":"1998","unstructured":"Rysana R, Zabka J, Peregin JH, Tesar V, Merta M, Rychlik I (1998) Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome. Nephrol Dial Transplant 13:2645\u20132647","journal-title":"Nephrol Dial Transplant"},{"key":"8112_CR20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1253\/jcj.64.541","volume":"64","author":"K Aizawa","year":"2000","unstructured":"Aizawa K, Nakamura T, Sumino H et al (2000) Renovascular hypertension observed in a patient with antiphospholipid-antibody syndrome. Jpn Circ J 64:541\u2013543","journal-title":"Jpn Circ J"},{"key":"8112_CR21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0272-6386(95)90603-7","volume":"26","author":"S Peribasekar","year":"1995","unstructured":"Peribasekar S, Chawla K, Rosner F, Depestre M (1995) Complete recovery from renal infarcts in a patient with mixed connective tissue disease. Am J Kidney Dis 26:649\u2013653","journal-title":"Am J Kidney Dis"},{"key":"8112_CR22","first-page":"1221","volume":"20","author":"GM Sonpal","year":"1993","unstructured":"Sonpal GM, Sharma A, Miller A (1993) Primary antiphospholipid antibody syndrome, renal infarction and hypertension. J Rheumatol 20:1221\u20131223","journal-title":"J Rheumatol"},{"key":"8112_CR23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2230.1984.tb00856.x","volume":"9","author":"G Hughes","year":"1984","unstructured":"Hughes G (1984) Connective tissue diseases and the skin. The 1983 Posser\u2013White Oration. Clin Exp Dermatol 9:535\u2013544","journal-title":"Clin Exp Dermatol"},{"key":"8112_CR24","first-page":"486","volume":"13","author":"GRV Hughes","year":"1987","unstructured":"Hughes GRV, Harris EN, Gharavi AE (1987) The anticardiolipin syndrome. J Rheumatol 13:486\u2013489","journal-title":"J Rheumatol"},{"key":"8112_CR25","first-page":"47","volume":"2","author":"RA Asherson","year":"1984","unstructured":"Asherson RA, Lanham JG, Hull RG et al (1984) Renal vein thrombosis in systemic lupus associated with the lupus anticoagulant. Clin Exp Rheumatol 2:47\u201351","journal-title":"Clin Exp Rheumatol"},{"key":"8112_CR26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/art.1780290121","volume":"29","author":"J Jouquan","year":"1986","unstructured":"Jouquan J, Pennec Y, Mottier D et al (1986) Accelerated hypertension associated with lupus anticoagulant and false positive VDRL in systemic lupus erythematosus. Arthritis Rheum 29:147","journal-title":"Arthritis Rheum"},{"key":"8112_CR27","first-page":"S360","volume":"35","author":"P Cacoub","year":"1992","unstructured":"Cacoub P, Piette JC, Beaufilis H et al (1992) Malignant hypertension in the antiphospholipid syndrome (APS) without lupus nephritis (abst). Arthritis Rheum 35:S360","journal-title":"Arthritis Rheum"},{"key":"8112_CR28","first-page":"795","volume":"68","author":"P Kincaid-Smith","year":"1988","unstructured":"Kincaid-Smith P, Fairley KF, Kloss M (1988) Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 68:795\u2013815","journal-title":"Q J Med"},{"key":"8112_CR29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/rheumatology\/30.6.471","volume":"30","author":"H Julkunen","year":"1991","unstructured":"Julkunen H, Kaaja R, Jouhikainen T et al (1991) Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives. Br J Rheumatol 30:471\u2013472","journal-title":"Br J Rheumatol"},{"key":"8112_CR30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","volume":"10","author":"D Nochy","year":"1999","unstructured":"Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507\u2013518","journal-title":"J Am Soc Nephrol"},{"key":"8112_CR31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","volume":"13","author":"E Daugas","year":"2002","unstructured":"Daugas E, Nochy D, Huong du LT et al (2002) Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13:42\u201352","journal-title":"J Am Soc Nephrol"},{"key":"8112_CR32","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.20433","volume":"50","author":"MG Tektonidou","year":"2004","unstructured":"Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50:2569\u20132579","journal-title":"Arthritis Rheum"},{"key":"8112_CR33","first-page":"1983","volume":"35","author":"MG Tektonidou","year":"2008","unstructured":"Tektonidou MG, Sotsiou F, Moutsopoulos HM (2008) Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary and systemic lupus erythematosus-related APS. J Rheumatol 35:1983\u20131988","journal-title":"J Rheumatol"},{"key":"8112_CR34","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/rheumatology\/keg302","volume":"42","author":"NA Dayal","year":"2003","unstructured":"Dayal NA, Isenberg DA (2003) End stage renal failure in primary antiphospholipid syndrome-case report and review of literature. Rheumatology (Oxford) 42:1128\u20131129","journal-title":"Rheumatology (Oxford)"},{"key":"8112_CR35","first-page":"465","volume":"11","author":"MA Asherson","year":"1993","unstructured":"Asherson MA, Khamashta MA, Hughes GRV (1993) Hypertension and the antiphospholipid antibodies. Clin Exp Rheumatol 11:465\u2013467","journal-title":"Clin Exp Rheumatol"},{"key":"8112_CR36","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archinte.1985.00360080059007","volume":"145","author":"HI Glueck","year":"1985","unstructured":"Glueck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M (1985) Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 145:1389\u20131395","journal-title":"Arch Intern Med"},{"key":"8112_CR37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1191\/0961203305lu2058oa","volume":"14","author":"DP D\u2019Cruz","year":"2005","unstructured":"D\u2019Cruz DP (2005) Renal manifestations of the antiphospholipid syndrome. Lupus 14:45\u201348","journal-title":"Lupus"},{"key":"8112_CR38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/ard.56.9.562","volume":"56","author":"NS Lai","year":"1997","unstructured":"Lai NS, Lan JL (1997) Renal vein thrombosis in Chinese patients with systemic lupus erythematosus. Ann Rheum Dis 56:562\u2013564","journal-title":"Ann Rheum Dis"},{"key":"8112_CR39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/art.1780270509","volume":"27","author":"G Mintz","year":"1984","unstructured":"Mintz G, Acevedo-Vazquez E, Guttierrez-Espinosa G et al (1984) Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Arthritis Rheum 27:539\u2013544","journal-title":"Arthritis Rheum"},{"key":"8112_CR40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0049-0172(94)90086-8","volume":"23","author":"JC Piette","year":"1994","unstructured":"Piette JC, Cacoub P, Wechsler B (1994) Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 23:357\u2013366","journal-title":"Semin Arthritis Rheum"},{"key":"8112_CR41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/6.8.543","volume":"6","author":"F Garcia-Martin","year":"1991","unstructured":"Garcia-Martin F, De Arriba G, Carrascosa T et al (1991) Anticardiolipin antibodies and lupus anticoagulant in end stage renal disease. Nephrol Dial Transplant 6:543\u2013547","journal-title":"Nephrol Dial Transplant"},{"key":"8112_CR42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000184984","volume":"49","author":"C Quereda","year":"1988","unstructured":"Quereda C, Pardo A, Lamas S et al (1988) Lupus-like in vitro anticoagulant activity in end-stage renal disease. Nephron 49:39\u201344","journal-title":"Nephron"},{"key":"8112_CR43","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/bmj.300.6741.1696","volume":"300","author":"C Gronhagen-Riska","year":"1990","unstructured":"Gronhagen-Riska C, Teppo AM, Healntera A et al (1990) Raised concentrations of antibodies to cardiolipin in patients receiving dialysis. BMJ 300:1696\u20131697","journal-title":"BMJ"},{"key":"8112_CR44","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ki.1995.352","volume":"58","author":"P Brunet","year":"1995","unstructured":"Brunet P, Aillaud MF, SanMarco M et al (1995) Antiphospholipid in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Kidney Int 58:794\u2013800","journal-title":"Kidney Int"},{"key":"8112_CR45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0272-6386(12)80383-0","volume":"23","author":"LN Pieto","year":"1994","unstructured":"Pieto LN, Suki WN (1994) Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies. Am J Kidney Dis 23:587\u2013590","journal-title":"Am J Kidney Dis"},{"key":"8112_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01698134","volume":"65","author":"T Sitter","year":"1992","unstructured":"Sitter T, Spannagl M, Schiff H (1992) Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 65:79\u201382","journal-title":"Ann Hematol"},{"key":"8112_CR47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0003-4975(99)00458-0","volume":"68","author":"DR Fastenau","year":"1999","unstructured":"Fastenau DR, Wagenknecht DR, McIntyre JA (1999) Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients. Ann Thorac Surg 68:137\u2013142","journal-title":"Ann Thorac Surg"},{"key":"8112_CR48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.semarthrit.2006.01.001","volume":"35","author":"I Uhtman","year":"2006","unstructured":"Uhtman I, Khamashta M (2006) Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum 35:360\u2013367","journal-title":"Semin Arthritis Rheum"},{"key":"8112_CR49","first-page":"89","volume":"12","author":"F Fabrizi","year":"1999","unstructured":"Fabrizi F, Sangiorgio R, Pontoriero G et al (1999) Antiphospholipid (aPL) antibodies in end stage renal disease. J Nephrol 12:89\u201394","journal-title":"J Nephrol"},{"key":"8112_CR50","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ndt\/7.12.1194","volume":"7","author":"SL Chew","year":"1992","unstructured":"Chew SL, Lins RL, Daelemans R, Zachee P, De Clerck LS, Vermylen J (1992) Are antiphospholipid antibodies clinically relevant in dialysis patients. Nephrol Dial Transpalnt 7:1194\u20131198","journal-title":"Nephrol Dial Transpalnt"},{"key":"8112_CR51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000045833","volume":"86","author":"YS Haviv","year":"2000","unstructured":"Haviv YS (2000) Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: cause or effect. Nephron 86:447\u2013454","journal-title":"Nephron"},{"key":"8112_CR52","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0272-6386(95)90656-8","volume":"26","author":"R Prakash","year":"1995","unstructured":"Prakash R, Miller CC, Suki W (1995) Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis 26:347\u2013352","journal-title":"Am J Kidney Dis"},{"key":"8112_CR53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1072-7515(99)00086-1","volume":"189","author":"CJ Lesar","year":"1999","unstructured":"Lesar CJ, Merrick HW, Smith MR (1999) Thrombotic complications resulting from hypercoaguable states in chronic hemodialysis vascular access. J Am Coll Sur 189:73\u201379","journal-title":"J Am Coll Sur"},{"key":"8112_CR54","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/1529-0131(199808)41:8<1438::AID-ART14>3.0.CO;2-A","volume":"41","author":"JH Stone","year":"1998","unstructured":"Stone JH, Amend WJ, Criswell LA (1998) Outcome of renal transplantation in ninety-seven cyclosporine -era patients with systemic lupus erythematosus and matched controls. Arthritis Rheum 41:1438\u20131445","journal-title":"Arthritis Rheum"},{"key":"8112_CR55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0272-6386(12)80986-3","volume":"23","author":"J Radhakrishnan","year":"1994","unstructured":"Radhakrishnan J, Williams GS, Appel GB et al (1994) Renal transplantation in anticardiolipin anrtibody-positive lupus erythematosus patients. Am J Kidney Dis 23:286\u2013289","journal-title":"Am J Kidney Dis"},{"key":"8112_CR56","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70009-0","volume":"34","author":"JH Stone","year":"1999","unstructured":"Stone JH, Amend WJC, Criswell LA (1999) Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am J Kidney Dis 34:1040\u20131047","journal-title":"Am J Kidney Dis"},{"key":"8112_CR57","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0272-6386(12)80383-0","volume":"23","author":"L Nied Prieto","year":"1994","unstructured":"Nied Prieto L, Suki NW (1994) Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies. Am J Kidney Dis 23:587\u2013590","journal-title":"Am J Kidney Dis"},{"key":"8112_CR58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00007890-199901150-00015","volume":"67","author":"D Ducloux","year":"1999","unstructured":"Ducloux D, Pellet E, Fournier V, Rebibou JM, Bresson-Vautrin C, Racadot E et al (1999) Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. Transplantation 67:90\u201393","journal-title":"Transplantation"},{"key":"8112_CR59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1053\/j.ajkd.2005.01.038","volume":"45","author":"G Moroni","year":"2005","unstructured":"Moroni G, Tantardini F, Galleli B, Quaglini S, Banfi G, Poli F et al (2005) The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis 45:901\u2013911","journal-title":"Am J Kidney Dis"},{"key":"8112_CR60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00007890-199907270-00014","volume":"68","author":"DR Wagenknecht","year":"1999","unstructured":"Wagenknecht DR, Becker DG, LeFor WM, McIntyre JA (1999) Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation 68:241\u2013246","journal-title":"Transplantation"},{"key":"8112_CR61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1399-0012.1994.tb00952.x","volume":"8","author":"G Montragon-Ramirez","year":"1994","unstructured":"Montragon-Ramirez G, Bochcchio T, Garcia-Torres R et al (1994) Recurrent renal thrombotic angioplasty after kidney transplantation in two patients with primary antiphospholipid syndrome (PAPS). Clin Transplant 8:93\u201396","journal-title":"Clin Transplant"},{"key":"8112_CR62","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-0012.1998.tb00995.x","volume":"12","author":"S Vaidya","year":"1998","unstructured":"Vaidya S, Wang CC, Gugliuzza C et al (1998) Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies. Clin Transplant 12:439\u2013444","journal-title":"Clin Transplant"},{"key":"8112_CR63","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/01.TP.0000119157.81765.46","volume":"77","author":"S Vaidya","year":"2004","unstructured":"Vaidya S, Gugliuzza K, Daller J (2004) Efficacy of anticoagulation therapy in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation 77:1046\u20131049","journal-title":"Transplantation"},{"key":"8112_CR64","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ndt\/4.10.854","volume":"4","author":"D Kleinknecht","year":"1989","unstructured":"Kleinknecht D, Bobrie G, Meyer O, Noel LH, Callard P, Ramdane M (1989) Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant. Nephrol Dial Transplant 4:854\u2013858","journal-title":"Nephrol Dial Transplant"},{"key":"8112_CR65","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000168093","volume":"10","author":"L Becquemont","year":"1990","unstructured":"Becquemont L, Thervent E, Rondeau E, Lacave R, Mougenot B, Sraer JD (1990) Systemic and renal fibrinolytic activity in a patient with anticardiolipin syndrome and renal thrombotic microangiopathy. Am J Nephrol 10:254\u2013258","journal-title":"Am J Nephrol"},{"key":"8112_CR66","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1681\/ASN.V15777","volume":"1","author":"V D\u2019Agati","year":"1990","unstructured":"D\u2019Agati V, Kunis C, Williams G, Appel GB (1990) Anti-cardiolipin antibody and renal disease: a report of three cases. J Am Soc Nephrol 1:777\u2013784","journal-title":"J Am Soc Nephrol"},{"key":"8112_CR67","first-page":"1181","volume":"19","author":"MC Amigo","year":"1992","unstructured":"Amigo MC, Garcia-Torres R, Robles M, Biochicchio T, Reyes PA (1992) Renal involvement in primary antiphospholipid syndrome. J Rheumatol 19:1181\u20131185","journal-title":"J Rheumatol"},{"key":"8112_CR68","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0046-8177(86)80293-3","volume":"17","author":"AB Magil","year":"1986","unstructured":"Magil AB, McFadden D, Rae A (1986) Lupus glomerulonephritis with thrombotic microangiopathy. Hum Pathol 17:192\u2013194","journal-title":"Hum Pathol"},{"key":"8112_CR69","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000188231","volume":"68","author":"S Domrongkitchaiporn","year":"1994","unstructured":"Domrongkitchaiporn S, Cameron EJ, Jetha N, Kassen BO, Sutton RA (1994) Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review. Nephron 68:128\u2013132","journal-title":"Nephron"},{"key":"8112_CR70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00005792-198103000-00001","volume":"60","author":"KS Kant","year":"1981","unstructured":"Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller MA, Hess EV (1981) Glomerular thrombosis in systemic lupus erythematosus. Prevalence and significance. Medicine 60:71\u201386","journal-title":"Medicine"},{"key":"8112_CR71","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archinte.1985.00360080059007","volume":"145","author":"HI Glueck","year":"1985","unstructured":"Glueck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M (1985) Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 145:1389\u20131395","journal-title":"Arch Intern Med"},{"key":"8112_CR72","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ki.1991.155","volume":"39","author":"G Frampton","year":"1991","unstructured":"Frampton G, Hicks J, Cameron JS (1991) Significance of anti-phospholipid antibodies in patients with lupus nephritis. Kidney Int 39:1225\u20131231","journal-title":"Kidney Int"},{"key":"8112_CR73","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0272-6386(12)70258-5","volume":"20","author":"E Farrugia","year":"1992","unstructured":"Farrugia E, Torres VE, Gastineau D, Michet CJ, Holley KE (1992) Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis 20:463\u2013471","journal-title":"Am J Kidney Dis"},{"key":"8112_CR74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0272-6386(12)80543-9","volume":"20","author":"MD Hughson","year":"1992","unstructured":"Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min KW, Silva F (1992) Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 20:150\u2013158","journal-title":"Am J Kidney Dis"},{"key":"8112_CR75","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/oxfordjournals.ndt.a027822","volume":"13","author":"F Bridoux","year":"1998","unstructured":"Bridoux F, Vrtovsnik F, Noel C, Saunier P, Mougenot B, Lemaitre V, Dracon M, Lelievre G, Vanhille P (1998) Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival. Nephrol Dial Transplant 13:298\u2013304","journal-title":"Nephrol Dial Transplant"},{"key":"8112_CR76","first-page":"1289","volume":"19","author":"RE Perez","year":"1992","unstructured":"Perez RE, McClendon JR, Lie JT (1992) Primary antiphospholipid syndrome with multiorgan arterial and venous thrombosis. J Rheumatol 19:1289\u20131292","journal-title":"J Rheumatol"},{"key":"8112_CR77","first-page":"89","volume-title":"The Antiphospholipid syndrome","author":"JT Lie","year":"1996","unstructured":"Lie JT (1996) Pathology of the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds) The Antiphospholipid syndrome. CRC, Boca Raton, FL, pp 89\u2013104"},{"key":"8112_CR78","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/0961203308090025","volume":"17","author":"JE Salmon","year":"2008","unstructured":"Salmon JE, de Groot PG (2008) Pathogenetic role of antiphospholipid antibodies. Lupus 17:405\u2013411","journal-title":"Lupus"},{"key":"8112_CR79","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncprheum0432","volume":"3","author":"JE Salmon","year":"2007","unstructured":"Salmon JE, Girardi G, Lockshin MD (2007) The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Nat Clin Pract Rheumatol 3:140\u2013147","journal-title":"Nat Clin Pract Rheumatol"},{"key":"8112_CR80","unstructured":"Oku K, Atsumi T, Bohgaki M et al (2008) Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis (in press) July 14"},{"issue":"suppl","key":"8112_CR81","first-page":"S359","volume":"48","author":"L Olguin","year":"2003","unstructured":"Olguin L, Calleja C, Hernandez C et al (2003) Primary antiphospholid antiphospholipid syndrome nephropathy despite anticoagulant therapy. Arthritis Rheum 48(suppl):S359","journal-title":"Arthritis Rheum"},{"key":"8112_CR82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0272-6386(95)90113-2","volume":"25","author":"MA Hamidou","year":"1995","unstructured":"Hamidou MA, Moreau A, Jego P et al (1995) Captopril and aspirin in the treatment of renal microangiopathy in primary antiphospholipid syndrome. Am J Kidney Dis 25:486\u2013488","journal-title":"Am J Kidney Dis"},{"key":"8112_CR83","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1191\/0961203303lu461oa","volume":"12","author":"C Korkmaz","year":"2003","unstructured":"Korkmaz C, Kabukcuoglu S, Isiksoy S et al (2003) Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy. Lupus 12:760\u2013765","journal-title":"Lupus"},{"key":"8112_CR84","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0272-6386(12)80519-1","volume":"15","author":"M Wilkowski","year":"1990","unstructured":"Wilkowski M, Arroyo R, McCabe K (1990) Glomerulonephritis in a patient with anticardiolipin antibody. Am J Kidney Dis 15:184\u2013186","journal-title":"Am J Kidney Dis"},{"key":"8112_CR85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5414\/CNP63471","volume":"63","author":"A Saracino","year":"2005","unstructured":"Saracino A, Ramunni A, Pannarale G et al (2005) Kidney disease associated with primary antiphospholipid ssyndrome: clinical signs and histopathological features in an experience of five cases. Clin Nephrol 63:471\u2013476","journal-title":"Clin Nephrol"},{"key":"8112_CR86","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0272-6386(03)00352-4","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Noel LH, Zuber J et al (2003) The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 41:1205\u20131211","journal-title":"Am J Kidney Dis"},{"key":"8112_CR87","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00005792-198103000-00001","volume":"60","author":"KS Kant","year":"1981","unstructured":"Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller MA, Hess EV (1981) Glomerular thrombosis in systemic lupus erythematosus. Prevalence and significance. Medicine 60:71\u201386","journal-title":"Medicine"},{"key":"8112_CR88","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/rheumatology\/30.6.422","volume":"30","author":"B Leaker","year":"1991","unstructured":"Leaker B, McGregor A, Griffiths M, Snaith M, Neild GH, Isenberg D (1991) Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis. Br J Rheumatol 30:422\u2013425","journal-title":"Br J Rheumatol"},{"key":"8112_CR89","first-page":"166","volume":"72","author":"SA Mayer","year":"2005","unstructured":"Mayer SA, Aledort LM (2005) Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies. Mt Sinai J Med 72:166\u2013175","journal-title":"Mt Sinai J Med"},{"key":"8112_CR90","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780240316","volume":"24","author":"FA Cecere","year":"1981","unstructured":"Cecere FA, Yoshinoya S, Pope RM (1981) Fatal thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus. Relationship to circulating immune complexes. Arthritis Rheum 24:550\u2013553","journal-title":"Arthritis Rheum"},{"key":"8112_CR91","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/91.6.401","volume":"91","author":"S Bandari","year":"1998","unstructured":"Bandari S, Harnden P, Brownjohn AM, Turney JH (1998) Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM 91:401\u2013409","journal-title":"QJM"},{"key":"8112_CR92","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.ajkd.2003.09.011","volume":"43","author":"G Moroni","year":"2004","unstructured":"Moroni G, Ventura D, Riva P et al (2004) Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 43:28\u201336","journal-title":"Am J Kidney Dis"},{"key":"8112_CR93","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0272-6386(12)80885-7","volume":"18","author":"G Banfi","year":"1991","unstructured":"Banfi G, Bertani T, Boeri V, Faraggiana T, Mazzucco G, Monga G et al (1991) Renal vascular lesions as a marker for poor prognosis in patients with lupus nephritis. Am J Kidney Dis 18:240\u2013248","journal-title":"Am J Kidney Dis"},{"key":"8112_CR94","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/096120339400300106","volume":"3","author":"JM Miranda","year":"1994","unstructured":"Miranda JM, Garcia-Torres R, Jara LJ et al (1994) Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. Analysis of 108 cases. Lupus 3:25\u201329","journal-title":"Lupus"},{"key":"8112_CR95","first-page":"508","volume":"19","author":"RA Asherson","year":"1992","unstructured":"Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508\u2013512","journal-title":"J Rheumatol"},{"key":"8112_CR96","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/art.22018","volume":"54","author":"S Bucciarelli","year":"2006","unstructured":"Bucciarelli S, Espinosa G, Cervera R et al (2006) European Forum on Antiphospholipid Antibodies. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 54:2568\u20132576","journal-title":"Arthritis Rheum"},{"key":"8112_CR97","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1002\/art.11359","volume":"48","author":"D Erkan","year":"2003","unstructured":"Erkan D, Cervera R, Asherson RA (2003) Catastrophic antiphospholipid syndrome. Where do we stand. Arthritis Rheum 48:3320\u20133327","journal-title":"Arthritis Rheum"},{"key":"8112_CR98","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/pgmj.67.786.385","volume":"66","author":"S Inam","year":"1991","unstructured":"Inam S, Sidki K, Al-Marshedy AR, Judzewitsch R (1991) Addison\u2019s disease, hypertension, renal and hepatic microthrombosis in \u201cprimary\u201d antiphospholipid syndrome. Postgrad Med J 66:385\u2013388","journal-title":"Postgrad Med J"},{"key":"8112_CR99","first-page":"1289","volume":"19","author":"RE Perez","year":"1992","unstructured":"Perez RE, McClendon JR, Lie JT (1992) Primary antiphospholipid syndrome with multiorgan arterial and venous thromboses. J Rheumatol 19:1289\u20131292","journal-title":"J Rheumatol"},{"key":"8112_CR100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1159\/000187378","volume":"64","author":"J Lacueva","year":"1993","unstructured":"Lacueva J, Enriquez R, Cabezuelo JB, Arenas MD, Teruel A, Gonzalez C (1993) Acute renal failure as first clinical manifestation of the primary antiphospholipid syndrome. Nephron 64:479\u2013480","journal-title":"Nephron"},{"key":"8112_CR101","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1681\/ASN.V5111882","volume":"5","author":"VR Peddi","year":"1995","unstructured":"Peddi VR, Kant KS (1995) Catastrophic secondary antiphospholipid syndrome with concomitant antithrombin III deficiency. J Am Soc Nephrol 5:1882\u20131887","journal-title":"J Am Soc Nephrol"},{"key":"8112_CR102","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00467-004-1761-0","volume":"20","author":"G Tsirpanlis","year":"2005","unstructured":"Tsirpanlis G, Moustakas G, Sakka E, Triantafyllis G, Sotsiou F, Liapis H et al (2005) Catastrophic antiphospholipid syndrome in a 14-year-old child. Pediatr Nephrol 20:519\u2013521","journal-title":"Pediatr Nephrol"},{"key":"8112_CR103","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00467-004-1734-3","volume":"20","author":"J Sharma","year":"2005","unstructured":"Sharma J, Karthik S, Rao S, Phadke K, Crasta J, Garg I (2005) Catastrophic antiphospholipid syndrome. Pediatr Nephrol 20:998\u2013999","journal-title":"Pediatr Nephrol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-008-8112-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-008-8112-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-008-8112-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T01:42:36Z","timestamp":1738719756000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-008-8112-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,2]]},"references-count":103,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["8112"],"URL":"https:\/\/doi.org\/10.1007\/s12016-008-8112-z","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,2]]}}}